Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Nat Prod Rep. 2020 May 13;37(6):797–826. doi: 10.1039/c9np00061e

Figure 10. NRF2 activating compounds that have been used in neuroprotective studies.

Figure 10.

In addition to these, other compounds discussed in other sections shown in other figures have been used in neuroprotective studies. A) Carnosic acid from Rosmarinus officinalis. B) Sulfuretin from Rhus verniciflua. C) Methysticin from Piper methysticum. D) Resveratrol. E) Thymol from Thymus vulgaris. F) 6-Dehydrogingerdione from Zingiber officinale. G) Xanthohumol from Humulus lupulus. H) Hydroxytyrosol from Olea europaea. I) 6-Shogaol from Zingiber officinale. J) Cardamonin from Alpinia katsumadae. K) Honokiol from Magnolia virginiana. L) Costunolide from Saussurea costus. M) Mangiferin from Mangifera indica. N) Chlorogenic acid from coffee. O) Lipoamide. Please see the text for details.